The decision by Washington to slash HIV funding for South Africa has sent shockwaves through Whitehall. Senior officials, speaking on condition of anonymity, have branded the move reckless. One source described it as a betrayal of decades of progress.
The cut, reportedly amounting to £200 million, threatens to unravel the gains made in the fight against AIDS. South Africa remains the epicentre of the global HIV epidemic. Nearly 8 million people are living with the virus.
The US funding was a cornerstone of the country's treatment programme. Without it, clinics face closure. Patients could lose access to antiretroviral drugs.
The political fallout is already being felt. Downing Street is scrambling to assess the damage. The Foreign Office has issued a terse statement expressing deep concern.
But behind closed doors, the anger is palpable. This is not just a funding cut. It is a signal.
A signal that America is retreating from its global health commitments. For the UK, which has long championed the fight against HIV, this poses a dilemma. Can we fill the gap?
Treasury sources indicate the coffers are empty. The aid budget is already stretched thin. The decision, sources say, was driven by domestic political pressures in the US.
But the consequences will be felt in the townships of Soweto and the clinics of Durban. The timing could not be worse. South Africa is already grappling with a struggling economy and high unemployment.
The health system is fragile. This cut could push it over the edge. Whitehall is now watching for further signals.
Is this a one-off or the start of a pattern? The fear is that it is the latter. The US has long been the world's largest donor to HIV programmes.
Any retreat will have massive implications. For now, the focus is on damage control. But the mood in Westminster is grim.
This is a blow to global health governance. And a stark reminder of how quickly the ground can shift. The question now is: what comes next?
